SER150

Serodus AS · Phase 2 active Small molecule

At a glance

Generic name	SER150
Sponsor	Serodus AS
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

SER150 vs Placebo in Diabetic Kidney Disease (PHASE2, PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

SER150 CI brief — competitive landscape report
SER150 updates RSS · CI watch RSS
Serodus AS portfolio CI